To date, the GLP-1 Supply Tracker has generated more than 50,000 crowdsourced shortage reports and thousands of supply reports, data which Ro has shared with the FDA
Potential for Type 2 Diabetes Remission Disease Modulation : The significant weight loss and improved insulin sensitivity associated with semaglutide use can lead to partial or complete remission of type 2 diabetes, particularly when combined with lifestyle interventions as part of a comprehensive medical weight loss plan
Dexfenfluramine and pergolide cause heart valve disease via valve metabolic reprogramming and ongoing matrix remodeling
This means our manufacturers have specific quality standards to ensure every product has the right identity, purity, strength and composition
On average, members who logged in to the GLP-1 Success Program at least 4 days each week (n=376) lost 22.20% body weight, and members who never logged in to the app (n=2,949) lost 17.20% body weight in 52 weeks